Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis

Acta Biochimica Polonica

Volumn 55, Issue 3, 2008, Pages 587-594

  Spiroski, Igor ^a   Kedev, Sashko ^a   Antov, Slobodan ^a   Arsov, Todor ^a   Krstevska, Marija ^a   Dzhekova Stojkova, Sloboda ^a   Bosilkova, Gordana ^a   Kostovska, Stojanka ^b   Trajkov, Dejan ^a   Petlichkovski, Aleksandar ^a   Strezova, Ana ^a   Efinska Mladenovska, Olivija ^a   Spiroski, Mirko ^a  

^a SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^b Institute of Transfusion Medicine   (Macedonia)

Author keywords

Deep venous thrombosis; Macedonians; MTHFR 1298; MTHFR 677; Occlusive artery disease; Plasma total homocysteine

Indexed keywords

EID: 56049120125     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2008_3065     Document Type: Article

References (39)

1. Ariyaratnam R, Casas JP, Whittaker J, Smeeth L, Hingorani AD, Sharma P (2007) Genetics of ischaemic stroke among persons of non-European descent: A meta-analysis of eight genes involving 32500 individuals. PLoS Med 4: e131.
2. Bailey LB, Duhaney RL, Maneval DR, Kauwell GP, Quinlivan EP, Davis SR, Cuadras A, Hutson AD, Gregory JF 3rd (2002) Vitamin B-12 status is inversely associated with plasma homocysteine in young women with C677T and/or A1298C methylenetetrahydrofolate reductase polymorphisms. J Nutr 132: 1872-1878.
3. Bezemer ID, Doggen CJ, Vos HL, Rosendaal FR (2007) No association between the common MTHFR 677C→T polymorphism and venous thrombosis: results from the MEGA study. Arch Intern Med 167: 497-501.
4. Cronin S, Furie KL, Kelly PJ (2005) Dose-related association of MTHFR 677T allele with risk of ischemic stroke evidence from a cumulative meta-analysis. Stroke 36: 1581-1587.
5. Den Heijer M, Lewington S, Clarke R (2005) Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 3: 292-399.
6. den Heijer M, Rosendaal FR, Blom HJ, Gerrits WB, Bos GM (1998) Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 80: 874-877.
7. Domagala TB, Adamek L, Nizankowska E, Sanak M, Szczeklik A (2002) Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease. Blood Coagul Fibrinolysis 13: 423-431.
8. Frantzen F, Faaren AL, Alfheim I, Nothei AK (1998) The enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem 44: 311-316.
9. Freitas AI, Mendonça I, Guerra G, Brión M, Reis RP, Carracedo A, Brehm A (2008) Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: The A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal). Thromb Res [Epub ahead of print].
10. Ghazouani L, Abboud N, Mtiraoui N, Zammiti W, Addad F, Amin H, Almawi WY, Mahjoub T (2008) Homocysteine and methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in Tunisian patients with severe coronary artery disease. J Thromb Thrombolysis [Epub ahead of print].
11. Goyette P, Sumner JS, Milos R, Duncan AMV, Rosenblatt DS, Matthews RG, Rozen R (1994) Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nature Genet 7: 195-200.
12. Goyette P, Pai A, Milos R, Frosst P, Tran P, Chen Z, Chan M, Rozen R (1998) Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome 9: 652-656.
13. Hoţoleanu C, Porojan-Iuga M, Rusu ML, Andercou A (2007) Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis. Rom J Intern Med 45: 159-164.
14. Keijzer MB, Borm GF, Blom HJ, Bos GM, Rosendaal FR, den Heijer M (2007) No interaction between factor V Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous thrombosis. Results of a meta-analysis of published studies and a large case-only study. Thromb Haemost 97: 32-37.
15. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG (2002) MTHFR Studies Collaboration Group: MTHFR 677C-T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288: 2023-2031.
16. Kothekar MA (2007) Homocysteine in cardiovascular disease: a culprit or an innocent bystander? Indian J Med Sci 61: 361-371.
17. Krstevska M (2001) Total homocysteine levels in healthy pre- and postmenopausal women. Acta Pharm 51: 225-231.
18. Krstevska M, Dzhekova-Stojkova S, Bosilkova G (2001) Distribution of the total homocysteine values in female population. Jugoslav Med Biochem 20: 207-211.
19. Lancaster A, Nelson MP, Meyer D, Thomson G, Single RM (2003) PyPop: a software framework for population genomics: analyzing large-scale multi-locus genotype data. Pac Symp Biocomput 514-525.
20. Lancaster AK, Single RM, Solberg OD, Nelson MP, Thomson G (2007) PyPop update - a software pipeline for large-scale multilocus population genomics. Tissue Antigens 69 (Suppl 1): 192-197.
21. Lewis SJ, Ebrahim S, Smith GD (2005) Meta-analysis of MTHFR 677C→T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ doi:10.1136: 1-6.
22. McNulty H, Pentieva K, Hoey L, Ward M (2008) Homocysteine, B-vitamins and CVD. Proc Nutr Soc 67: 232-237.
23. Ogino S, Wilson RB (2003) Genotype and haplotype distributions of MTHFR677C>T and 1298A>C single nucleotide polymorphisms: a meta-analysis. J Hum Genet 48: 1-7.
24. Poduri A, Mukherjee D, Sud K, Kohli HS, Sakhuja V, Khullar M (2008) MTHFR A1298C polymorphism is associated with cardiovascular risk in end stage renal disease in North Indians. Mol Cell Biochem 308: 43-50.
25. Refsum H, Ueland PM (1998) Recent data are not in conflict with homocysteine as a cardiovascular risk factor. Curr Opin Lipidol 9: 533-539.
26. Salomon O, Rosenberg N, Zivelin A, Steinberg DM, Kornbrot N, Dardik R, Inbal A, Seligsohn U (2001) Methionine synthase A2756G and methylenetetrahydrofolate reductase A1298C polymorphisms are not risk factors for idiopathic venous thromboembolism. Hematol J 2: 38-41.
27. Sawuła W, Banecka-Majkutewicz Z, Kadziński L, Jakóbkiewicz-Banecka J, Wegrzyn G, Nyka W, Banecki B (2008) Improved HPLC method for total plasma homocysteine detection and quantification. Acta Biochim Polon 55: 119-125.
28. Sazci A, Ergul E, Tuncer N, Akpinar G, Kara I (2006) Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: Dual effect of MTHFR polymorphisms C677T and A1298C. Brain Res Bull 71: 45-50.
29. Single RM, Meyer D, Mack SJ, Lancaster A, Erlich HA, Thomson G (2007) 14th International HLA and Immunogenetics Workshop: report of progress in methodology, data collection, and analyses. Tissue Antigens 69 (Suppl 1): 185-187.
30. Souto JC, Blanco-Vaca F, Soria JM, Buil A, Almasy L, Ordonez-Llanos J, Martin-Campos JM, Lathrop M, Stone W, Blangero J, Fontcuberta J (2005) A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT Project. Am J Hum Genet 76: 925-933.
31. Spiroski M, Arsov T, Petlichkovski A, Strezova A, Trajkov D, Efinska-Mladenovska O, Zaharieva E (2005) Case Study: Macedonian Human DNA Bank (hDNAMKD) as a source for public health genetics. In: Health Determinants in the Scope of New Public Health, Georgieva L, Burazeri G, ed, pp 33-44. Hans Jacobs Company: Sofia.
32. Spiroski I, Kedev S, Antov S, Arsov T, Krstevska M, Dzhekova-Stojkova S, Kostovska S, Trajkov D, Petlichkovski A, Strezova A, Efinska-Mladenovska O, Spiroski M (2008) Association of methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genetic polymorphisms with occlusive artery disease and deep venous thrombosis in Macedonians. Croat Med J 49: 39-49.
33. Strandhagen E, Zetterberg H, Aires N, Palmér M, Rymo L, Blennow K, Landaas S, Thelle DS (2004) The methylenetetrahydrofolate reductase C677T polymorphism is a major determinant of coffee-induced increase of plasma homocysteine: a randomized placebo controlled study. Int J Mol Med 13: 811-815.
34. Towner P (1995) Purification of DNA. Essential Molecular Biology. Brown TA ed, pp 47-54. Oxford University Press, Oxford.
35. Tunbridge EM, Harrison PJ, Warden DR, Johnston C, Refsum H, Smith AD (2008) Polymorphisms in the catechol-O-methyltransferase (COMT) gene influence plasma total homocysteine levels. Am J Med Genet B Neuropsychiatr Genet [Epub ahead of print].
36. van der Linden IJ, den Heijer M, Afman LA, Gellekink H, Vermeulen SH, Kluijtmans LA, Blom HJ (2006) The methionine synthase reductase 66A>G polymorphism is a maternal risk factor for spina bifida. J Mol Med 84: 1047-1054.
37. Wald DS, Law M, Morris JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325: 1202.
38. Yang QH, Botto LD, Gallagher M, Friedman JM, Sanders CL, Koontz D, Nikolova S, Erickson JD, Steinberg K (2008) Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. Am J Clin Nutr 88: 232-246.
39. Zak I, Niemiec P, Sarecka B, Balcerzyk A, Ciemniewski Z, Rudowska E, Dylag S (2003) Carrier-state of D allele in ACE gene insertion/deletion polymorphism is associated with coronary artery disease, in contrast to the C677 - >T transition in the MTHFR gene. Acta Biochim Polon 50: 527-534.